Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
AQF
0.00%
$1.85
AUSTRALIAN GOVERNANCE MASTERS INDEX FUND LIMITED
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AQF | Ann: Removal from Official List | 16/07/18 | 0 | 412 | |||
|
|||||||
AQF | Ann: Net Tangible Asset Backing | 13/07/18 | 0 | 870 | |||
|
|||||||
AQF | Ann: Initial Director's Interest Notice - Warwick Keneally | 13/07/18 | 0 | 328 | |||
|
|||||||
AQF | Ann: Initial Director's Interest Notice - Jaclyn Strelow | 13/07/18 | 0 | 331 | |||
|
|||||||
AQF | Ann: Initial Director's Interest Notice - Alexander MacLachlan | 13/07/18 | 0 | 303 | |||
|
|||||||
AQF | Ann: Final Director's Interest Notice - Nerida Cole | 13/07/18 | 0 | 313 | |||
|
|||||||
AQF | Ann: Final Director's Interest Notice - Josephine Tan | 13/07/18 | 0 | 257 | |||
|
|||||||
AQF | Ann: Final Director's Interest Notice - Jeffrey Whalan | 13/07/18 | 0 | 401 | |||
|
See All Discussions